Wednesday, July 8, 2026

biotech · Pediatric acute-onset neuropsychiatric syndrome (PANS) · acute hereditary angioedema attacks · MAZE

Maze Therapeutics

News and analysis for Maze Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

South San Francisco, USA HQ
2018 Founded
152 Employees
Public company Type
MAZE · NYSE Ticker
Company details
Status
Public
HQ
South San Francisco, USA
Founded
2018
Employees
152
Programs
8
Drugs
12
Patents
60
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Maze Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Maze Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Maze Therapeutics yet.

Back to company overview →